Lactobacillus reuteri strain combination in Helicobacter pylori infection: a randomized, double-blind, placebo-controlled study.

Goals: The goals of this study were to investigate the role of a new probiotic preparation (Lactobacillus reuteri DSM 17938 and L. reuteri ATCC PTA 6475) in Helicobacter pylori infection.

Background: Specific probiotic strains play a role in H.

Inhibition of Helicobacter pylori infection in humans by Lactobacillus reuteri ATCC 55730 and effect on eradication therapy: a pilot study.

Background: Several studies report an inhibitory effect of probiotics on Helicobacter pylori.

Aim: To test whether Lactobacillus reuteri ATCC 55730 reduces H. pylori intragastric load in vivo, decreases dyspeptic symptoms, and affects eradication rates after conventional treatment.

[Treatment for Helicobacter pylori in children. Recent advances].

Helicobacter pylori (H. pylori) is a highly prevalent pathogen considered as an aetiological factor for gastric ulcers and gastric cancer. Most children colonized by H.